# NSN 6505-01-238-5632: Loperamide Hydrochloride Capsule

NSN 6505-01-238-5632 (also written 6505012385632; NIIN 01-238-5632) is a loperamide hydrochloride capsule in Federal Supply Class 6505, Drugs and Biologicals. 1 manufacturer part number from 1 supplier is on record. It was last purchased in Oct 2026.

## Identification

- NSN: 6505-01-238-5632 (6505012385632)
- NIIN: 01-238-5632 (012385632)
- Item name: LOPERAMIDE HYDROCHLORIDE CAPSULE
- Federal Supply Class: [FSC 6505 Drugs and Biologicals](https://nsnexplorer.com/fsc/6505/)
- Federal Supply Group: [FSG 65](https://nsnexplorer.com/group/65/)
- Acquisition method suffix code: AMSC Z: a commercial, nondevelopmental or off-the-shelf item. (observed 2026-10-10)
- Acquisition method code: 3

## Characteristics

| Code | Requirement | Reply |
| --- | --- | --- |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS LOPERAMIDE HYDROCHLORIDE ACTIVE INGREDIENT 2.000 |
| CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | LOPERAMIDE HYDROCHLORIDE CAPSULES 2MG I.S. 100S PG |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |
| FEAT | SPECIAL FEATURES | 100 CAPSULES; STRIP OR CARD |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |

## Part numbers

| Part number | CAGE | Supplier | Source |
| --- | --- | --- | --- |
| NDC51079-0690-20 | 65751 | MYLAN INSTITUTIONAL INC | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |

## Contract awards

Newest first.

| Date | Award | Description | Recipient | Amount |
| --- | --- | --- | --- | --- |
| 2026-10-08 | [SPE2DX25D9900/SPE2DP27F0148](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505012385632) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $1,145.76 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0018](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505012385632) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $286.44 |
| 2026-09-29 | [SPE2DX25D9900/SPE2DP26F024W](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505012385632) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $190.96 |
| 2026-09-29 | [SPE2DX25D9900/SPE2DP26F027Z](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505012385632) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $190.96 |
| 2026-09-25 | [SPE2DX25D9900/SPE2DP26F014J](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505012385632) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $95.48 |
| 2026-09-23 | [SPE2DX25D9900/SPE2DP26F007S](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505012385632) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $381.92 |
| 2026-09-17 | [SPE2DX25D9900/SPE2DP26F002W](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505012385632) | LOPERAMIDE HYDROCHLORIDE CAPSULES | DMS PHARMACEUTICAL GROUP INC | $95.48 |

## Sources

- DLA DIBBS RFQs for this NSN: https://www.dibbs.bsm.dla.mil/RFQ/RFQNsn.aspx?value=6505012385632&category=nsn
- DLA DIBBS awards for this NSN: https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505012385632
- AMSC record: https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/
- USAspending contract actions (each award above links to its record)
- All data is public U.S. government data; every row above links to its source record where one exists.

Canonical page: https://nsnexplorer.com/nsn/6505-01-238-5632/
JSON: https://nsnexplorer.com/api/nsn/6505-01-238-5632.json